Chronic inflammation and immunologic-based constraints in malignant disease

Immunotherapy. 2011 Oct;3(10):1265-74. doi: 10.2217/imt.11.113.

Abstract

Acute inflammatory reactions benefit the host by supporting the effective clearance of pathogens and fostering wound healing, in addition to other self-preservative processes. However, when the inflammatory program is not resolved, becoming chronic in nature, it creates an environment conducive to cancer development and progression. Therefore, minimizing exposure to risk factors that contribute to chronic inflammation and reconditioning the host towards a state of (at least locoregional) acute inflammation would meaningfully impact cancer incidence and its treatment, respectively. Regarding cancer therapy, combinational treatments that both disrupt chronic inflammation and install specific adaptive type I immunity are predicted to enhance quality of life and extend the overall survival of patients.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acute Disease
  • Adaptive Immunity
  • Animals
  • Cell Transformation, Neoplastic / immunology
  • Chronic Disease
  • Disease Progression
  • Humans
  • Immunotherapy*
  • Inflammation*
  • Neoplasms / immunology*
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Risk Factors
  • Th1 Cells / immunology